Parathyroid hormone and premature thymus ageing in patients with chronic kidney disease.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
28 01 2019
Historique:
received: 01 08 2018
accepted: 07 12 2018
entrez: 30 1 2019
pubmed: 30 1 2019
medline: 30 7 2020
Statut: epublish

Résumé

Premature immune ageing, including thymic atrophy, is observed in patients with chronic kidney disease (CKD). Parathyroid hormone (PTH) and fibroblast growth factor 23 (FGF23), which are mineral and bone disorder (MBD)-related factors, affect immune cells and possibly cause thymic atrophy. We examined the cross-sectional association between thymic atrophy, evaluated as the number of CD3

Identifiants

pubmed: 30692566
doi: 10.1038/s41598-018-37511-9
pii: 10.1038/s41598-018-37511-9
pmc: PMC6349929
doi:

Substances chimiques

FGF23 protein, human 0
Parathyroid Hormone 0
Fibroblast Growth Factors 62031-54-3
Fibroblast Growth Factor-23 7Q7P4S7RRE
Alkaline Phosphatase EC 3.1.3.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

813

Références

J Clin Invest. 2004 Feb;113(4):561-8
pubmed: 14966565
J Clin Invest. 2005 Apr;115(4):930-9
pubmed: 15776111
N Engl J Med. 2006 Dec 7;355(23):2427-43
pubmed: 17145742
J Pathol. 2007 Jan;211(2):144-56
pubmed: 17200946
Eur J Immunol. 2007 Nov;37(11):3270-80
pubmed: 17935071
Blood. 2009 Jan 22;113(4):769-74
pubmed: 18583570
Am J Kidney Dis. 2009 Apr;53(4 Suppl 4):S3-10
pubmed: 19285609
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088
J Nephrol. 2010 Nov-Dec;23(6):693-8
pubmed: 20301083
FASEB J. 2010 Sep;24(9):3562-71
pubmed: 20418498
Kidney Int. 2011 Jul;80(2):208-17
pubmed: 21525849
Kidney Int. 2011 Sep;80(6):572-86
pubmed: 21750584
Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):E725-33
pubmed: 22393015
Bone. 2012 Jun;50(6):1266-74
pubmed: 22425694
J Neuroimmune Pharmacol. 2012 Dec;7(4):750-62
pubmed: 22535304
Blood. 2012 Nov 22;120(22):4352-62
pubmed: 22955916
J Clin Endocrinol Metab. 2013 Jun;98(6):2544-52
pubmed: 23585664
PLoS One. 2013 Aug 23;8(8):e71498
pubmed: 24009662
Front Immunol. 2013 Oct 31;4:322
pubmed: 24198816
J Am Soc Nephrol. 2014 Jun;25(6):1349-56
pubmed: 24511120
Stem Cells. 2014 Aug;32(8):2245-55
pubmed: 24648356
Kidney Int Suppl (2011). 2013 Dec;3(5):469-475
pubmed: 25019032
PLoS One. 2014 Jul 17;9(7):e102276
pubmed: 25033287
Am J Transplant. 2015 Apr;15(4):1028-38
pubmed: 25758660
J Am Soc Nephrol. 2016 Jan;27(1):227-37
pubmed: 25971439
Atherosclerosis. 2015 Nov;243(1):71-6
pubmed: 26363435
Cell Metab. 2015 Dec 1;22(6):1020-32
pubmed: 26437603
Cell Metab. 2015 Nov 3;22(5):799-810
pubmed: 26456334
Blood. 2015 Nov 26;126(22):2443-51
pubmed: 26468230
Cell Metab. 2016 Feb 9;23(2):315-23
pubmed: 26669699
J Atheroscler Thromb. 2016 May 2;23(5):632-43
pubmed: 26754173
J Clin Invest. 2016 Mar 1;126(3):962-74
pubmed: 26878171
Kidney Int. 2016 May;89(5):1136-1143
pubmed: 27083287
PLoS One. 2016 Jun 16;11(6):e0157361
pubmed: 27310428
Kidney Int. 2016 Dec;90(6):1184-1190
pubmed: 27653840
Clin Exp Nephrol. 2017 Mar;21(Suppl 1):9-20
pubmed: 27942882
J Am Soc Nephrol. 2017 Apr;28(4):1239-1246
pubmed: 28122946
Sci Rep. 2017 Apr 11;7(1):785
pubmed: 28400578
Mol Biol Cell. 2017 Jul 1;28(13):1792-1803
pubmed: 28495797
J Clin Endocrinol Metab. 2017 Dec 1;102(12):4648-4657
pubmed: 29029099
Am J Pathol. 1976 Jul;84(1):1-10
pubmed: 7140
Nature. 1997 Nov 6;390(6655):45-51
pubmed: 9363890

Auteurs

Kenichiro Iio (K)

Department of Nephrology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan. iioken16@outlook.com.

Daijiro Kabata (D)

Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Rei Iio (R)

Department of Kidney Disease and Hypertension, Osaka General Medical Center, Osaka, Japan.

Yosuke Imai (Y)

Department of Nephrology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan.

Masaki Hatanaka (M)

Department of Nephrology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan.

Hiroki Omori (H)

Department of Nephrology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan.

Yoshihiko Hoshida (Y)

Department of Pathology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan.

Yukihiko Saeki (Y)

Department of Clinical Research, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan.

Ayumi Shintani (A)

Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.

Takayuki Hamano (T)

Department of Inter-Organ Communication Research in Kidney Disease, Osaka University Graduate School of Medicine, Suita, Japan.

Yoshitaka Isaka (Y)

Department of Nephrology, Osaka University Graduate School of Medicine, Suita, Japan.

Yutaka Ando (Y)

Department of Nephrology, National Hospital Organization Osaka Minami Medical Center, Kawachinagano, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH